secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001641172-25-016719
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $67,860 convertible note with 35% conversion discount to 1800 Diagonal Lending
--------------------------------------------------------------------------------

- Principal $67,860 for net $58,000; matures Apr 16, 2026; 15% one-time interest.
- Conversion at 65% of lowest trading price in prior 10 days (35% discount); dilution risk.
- Payments: $39,019.50 on Dec 15, 2025; then $9,754.88 on Jan 15, Feb 15, Mar 15, Apr 15, 2026.
- Default triggers immediate acceleration; includes failure to pay, maintain OTC listing, or SEC reporting.
- Proceeds for general working capital; note issued under Regulation D, not registered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225016719/0001641172-25-016719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225016719/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer